About ATMP Sweden

Together for the benefit of patients

ATMP Sweden is a support organization for the Swedish National cell and gene therapy pharmaceutical (ATMP) network.

It provides centralizing, coordinating and communication functions to Swedish ATMP stakeholders towards making Sweden ‘world leading in ATMP by 2030’ and acts as a central contact point Inter/nationally for the Swedish ATMP field.

While open to all Swedish ATMP stakeholders, the ATMP Sweden network was founded through the Vinnova funded projects CAMP and Swelife-ATMP and now also plays a large role within the Vinnova funded ATMP Innovation Milieu.

Other Swedish ATMP specific networks within the ATMP Sweden umbrella include NextGenNK focused on cost effective development of Natural Killer (NK) cell based therapies and SWECARNET, Sweden’s network for clinical use of CAR T cells.

ATMP Sweden runs the annual Swedish conferences “ATMP Sweden” and the “ATMP world tour” as well as maintaining the atmpsweden.se website, LinkedIn page and sending a quarterly newsletter updating on Swedish ATMP developments.